Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pro Dex (PDEX) Net Income towards Common Stockholders (2016 - 2025)

Pro Dex's Net Income towards Common Stockholders history spans 13 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 7.21% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $11.3 million, up 68.03%, while the annual FY2025 figure was $9.0 million, 322.1% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $2.2 million at Pro Dex, down from $4.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $4.7 million in Q3 2025 and bottomed at -$615000.0 in Q3 2023.
  • The 5-year median for Net Income towards Common Stockholders is $1.3 million (2021), against an average of $1.6 million.
  • The largest annual shift saw Net Income towards Common Stockholders plummeted 151.12% in 2023 before it soared 500.98% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $1.2 million in 2021, then decreased by 27.36% to $879000.0 in 2022, then tumbled by 43.12% to $500000.0 in 2023, then soared by 308.0% to $2.0 million in 2024, then increased by 7.21% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Net Income towards Common Stockholders are $2.2 million (Q4 2025), $4.7 million (Q3 2025), and $1.2 million (Q2 2025).